117 related articles for article (PubMed ID: 27665178)
1. Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure-activity relationships and fluorescence properties.
Kinoshita M; Negishi M; Sakai H; Hirano T; Mori S; Fujii S; Kagechika H; Tanatani A
Bioorg Med Chem; 2016 Nov; 24(21):5602-5610. PubMed ID: 27665178
[TBL] [Abstract][Full Text] [Related]
2. 6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.
Sakai H; Hirano T; Mori S; Fujii S; Masuno H; Kinoshita M; Kagechika H; Tanatani A
J Med Chem; 2011 Oct; 54(20):7055-65. PubMed ID: 21916484
[TBL] [Abstract][Full Text] [Related]
3. Development of 1,3-diphenyladamantane derivatives as nonsteroidal progesterone receptor antagonists.
Mori S; Takeuchi Y; Tanatani A; Kagechika H; Fujii S
Bioorg Med Chem; 2015 Feb; 23(4):803-9. PubMed ID: 25593098
[TBL] [Abstract][Full Text] [Related]
4. Development of p-carborane-based nonsteroidal progesterone receptor antagonists.
Fujii S; Nakano E; Yanagida N; Mori S; Masuno H; Kagechika H
Bioorg Med Chem; 2014 Oct; 22(19):5329-37. PubMed ID: 25151087
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Phenylamino-1,3,5-triazine Scaffold.
Kaitoh K; Nakatsu A; Mori S; Kagechika H; Hashimoto Y; Fujii S
Chem Pharm Bull (Tokyo); 2019; 67(6):566-575. PubMed ID: 31155562
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C'-diphenylcarborane scaffold as a hydrophobic pharmacophore.
Fujii S; Yamada A; Nakano E; Takeuchi Y; Mori S; Masuno H; Kagechika H
Eur J Med Chem; 2014 Sep; 84():264-77. PubMed ID: 25036787
[TBL] [Abstract][Full Text] [Related]
7. MAO inhibitory activity of 2-arylbenzofurans versus 3-arylcoumarins: synthesis, in vitro study, and docking calculations.
Ferino G; Cadoni E; Matos MJ; Quezada E; Uriarte E; Santana L; Vilar S; Tatonetti NP; Yáñez M; Viña D; Picciau C; Serra S; Delogu G
ChemMedChem; 2013 Jun; 8(6):956-66. PubMed ID: 23589499
[TBL] [Abstract][Full Text] [Related]
8. Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy.
Yang L; Hu Z; Luo J; Tang C; Zhang S; Ning W; Dong C; Huang J; Liu X; Zhou HB
Bioorg Med Chem; 2017 Jul; 25(13):3531-3539. PubMed ID: 28506582
[TBL] [Abstract][Full Text] [Related]
9. Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF
Mori S; Tsuemoto N; Kasagawa T; Nakano E; Fujii S; Kagechika H
Chem Pharm Bull (Tokyo); 2019; 67(12):1278-1283. PubMed ID: 31787654
[TBL] [Abstract][Full Text] [Related]
10. Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.
Salar U; Khan KM; Iqbal J; Ejaz SA; Hameed A; Al-Rashida M; Perveen S; Tahir MN
Eur J Med Chem; 2017 May; 131():29-47. PubMed ID: 28288318
[TBL] [Abstract][Full Text] [Related]
11. Development of nonsteroidal glucocorticoid receptor modulators based on N-benzyl-N-(4-phenoxyphenyl)benzenesulfonamide scaffold.
Yoshioka H; Yamada A; Nishiyama Y; Kagechika H; Hashimoto Y; Fujii S
Bioorg Med Chem; 2017 Jul; 25(13):3461-3470. PubMed ID: 28506584
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antioxidant and antichagasic properties of a selected series of hydroxy-3-arylcoumarins.
Robledo-O'Ryan N; Matos MJ; Vazquez-Rodriguez S; Santana L; Uriarte E; Moncada-Basualto M; Mura F; Lapier M; Maya JD; Olea-Azar C
Bioorg Med Chem; 2017 Jan; 25(2):621-632. PubMed ID: 27908757
[TBL] [Abstract][Full Text] [Related]
13. Novel Non-steroidal Progesterone Receptor Ligands Based on m-Carborane Containing a Secondary Alcohol: Effect of Chirality on Ligand Activity.
Mori S; Takagaki R; Fujii S; Urushibara K; Tanatani A; Kagechika H
Chem Pharm Bull (Tokyo); 2017; 65(11):1051-1057. PubMed ID: 29093292
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Inhibition of Human Placental Glutathione S-Transferase by 3-Arylcoumarin Derivatives.
Alparslan MM; Danış Ö
Arch Pharm (Weinheim); 2015 Sep; 348(9):635-42. PubMed ID: 26205366
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
Lv N; Sun M; Liu C; Li J
Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins.
Matos MJ; Hogger V; Gaspar A; Kachler S; Borges F; Uriarte E; Santana L; Klotz KN
J Pharm Pharmacol; 2013 Nov; 65(11):1590-7. PubMed ID: 24118065
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1).
Gokce B; Gencer N; Arslan O; Karatas MO; Alici B
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):534-7. PubMed ID: 25982292
[TBL] [Abstract][Full Text] [Related]
20. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
